Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sysnav Healthcare does not develop drugs but provides qualified digital endpoints for clinical trials. Its Stride Velocity 95th Centile (SV95C) digital outcome measure for ambulant Duchenne muscular dystrophy has been formally qualified by the European Medicines Agency as a primary endpoint in superiority studies as an alternative to the 6‑Minute Walking Test, when supported by consistent secondary endpoints.[1][4] The company’s ActiMyo and Syde wearable devices are used in ongoing neuromuscular and movement‑disorder trials to generate real‑world evidence-grade data.[1][4][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sysnav Healthcare.